The University of Southampton spin-out and pharmaceutical company will use the recent investment to begin clinical trials of its Microcycle platform. Curve Therapeutics is working to develop new drugs for difficult-to-address cancer targets with its novel screening platform, Microcycle. The gene-encoded platform enables cyclic peptides – an amino acid...